Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Clinical trial NCT06279351 · RECRUITING
Trial details
- NCT number
- NCT06279351
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-11
- Primary completion
- 2025-12-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.